C07D - Heterocyclic compounds

More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)

Patents for C07D - Heterocyclic compounds (10,420)
05/2011
05/03/2011	CA2576067C Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
04/2011
04/28/2011	US20110098292 New Compounds Useful for Treating CNS Disorders
04/27/2011	CN1810802B 3-substituted-4-pyrimidone derivatives
04/21/2011	US20110092813 Multi-mode internal imaging
04/20/2011	EP2311850A1 Anti-cancer cyclopenta[g]quinazoline compounds
04/20/2011	EP2311825A1 Pyrimidineamines as angiogenesis modulators
04/20/2011	EP1603887B1 Hiv replication inhibiting indane substituted pyrimidines
04/20/2011	CN1830445B Composition of tropane derivatives having therapy use and polymorph thereof
04/19/2011	CA2453505C Preparation of aminopyrimidine compounds
04/14/2011	US20110086859 Alkyl substituted indoloquinoxalines
04/13/2011	EP1140085B1 Azabicycloalkanes as ccr5 modulators
04/13/2011	CN102010373A Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
04/07/2011	US20110082107 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
04/05/2011	US7919617 Cytokine inhibitors
03/2011
03/31/2011	US20110077266 Diamine Derivatives
03/30/2011	CN101445483B Method for preparing pesticide
03/29/2011	US7915254 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents
03/29/2011	CA2468715C Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
03/29/2011	CA2299139C 4-phenyl-pyridine derivatives
03/23/2011	EP2298761A1 HIV inhibiting pyrimidines derivatives
03/23/2011	EP2298749A1 Process for the preparation of Thioethers
03/23/2011	EP1278748B1 Inhibitors of human phosphatidyl-inositol 3-kinase delta
03/22/2011	US7910589 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
03/22/2011	CA2471628C Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, their preparation and their therapeutic application
03/22/2011	CA2396186C Agents for the treatment of skin disorders
03/17/2011	US20110065938 Method for the preparation of escitalopram
03/17/2011	US20110065736 Quinazoline derivatives as vegf inhibitors
03/16/2011	EP2295436A1 2-Phenyl-subsitituted Imidazotriazinones as Phosphodiesterase V inhibitors
03/16/2011	EP2295415A1 Quinazoline derivatives
03/15/2011	US7906646 Spirocyclic heterocyclic derivatives and methods of their use
03/15/2011	US7906516 Carbonyl compounds
03/15/2011	CA2562982C Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
03/15/2011	CA2502769C 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof
03/15/2011	CA2432000C Pyrimidineamines as angiogenesis modulators
03/15/2011	CA2426921C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
03/09/2011	EP2292600A1 Crystaline forms VI and VII of atorvastatin calcium
03/09/2011	CN1582274B Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
03/08/2011	CA2689051C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
03/02/2011	EP1001945B1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES
03/01/2011	US7897796 Treating the taxane mixture (biomass extract derived from Taxus media cultivars) with an amine attached to a silica matrix, e.g., methylated polyethylenimine bonded silica, and elution
03/01/2011	US7897599 Cytokine inhibitors
02/2011
02/24/2011	US20110046109 2,4,8-trisubstituted-8h-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy
02/23/2011	EP2286811A1 Chemokine receptor antagonists and methods of use thereof
02/23/2011	EP1697360B1 Novel crystalline forms of 2, 3 dimethyl-8- (2, 6-dimethylbenzylamino) -n-hydroxyethyl-imidazo 1, 2-a pyridine-6-carboxamide mesylate salt.
02/23/2011	CN101979382A Aminoindazole derivatives and use thereof as kinase inhibitors
02/22/2011	US7893084 Viral polymerase inhibitors
02/22/2011	US7893068 Physiologically active substances
02/17/2011	US20110039802 Npy y5 antagonist
02/15/2011	US7888331 Ganglioside compositions and methods of use
02/15/2011	CA2689052C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
02/15/2011	CA2481460C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics
02/15/2011	CA2461348C [[2-(amino-3,4-dioxo-1cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain
02/15/2011	CA2450890C Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r- and s-citalopram
02/15/2011	CA2449234C Quinazoline derivatives which promote the release of parathyroid hormone
02/15/2011	CA2247420C Combination therapy for osteoporosis
02/09/2011	EP2281815A1 4-(Acetylamino)-3-[(4-chlorophenyl)thio]-2-methyl-1H-indole-1-acetic acid ethyl ester intermediate compound
02/08/2011	CA2446924C 2-iminopyrrolidine derivatives
02/02/2011	EP2279751A2 Stabilisation of macrolides
02/02/2011	CN101961497A Inhibition of Syk kinase expression
02/01/2011	US7881773 Multi-mode internal imaging
02/01/2011	CA2688915C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
02/01/2011	CA2509554C Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors
02/01/2011	CA2482972C The use of hydroxypyridone-derivatives in wound healing
02/01/2011	CA2459449C Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia
01/2011
01/27/2011	US20110021628 CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG
01/27/2011	US20110021495 Quinazoles useful as modulators of ion channels
01/26/2011	CN101955494A Metal complexes of N-heterocyclic carbenes as radiopharmaceuticals and antibiotics
01/25/2011	US7875611 Ion channel modulating compounds and uses thereof
01/25/2011	CA2589329C Composition for controlling harmful bio-organisms and method for controlling harmful bio-organisms using the same
01/20/2011	US20110015185 Benzofuran Compounds
01/19/2011	EP2275416A1 Biologically active methylene blue derivatives
01/19/2011	CN101947218A Method for modulating calcium ion-release-activated calcium ion channels
01/19/2011	CN101560213B Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application
01/19/2011	CN101362731B Heterocyclic compounds and methods of use
01/18/2011	US7871619 Using orphan receptors expressed on cell surfaces as screening tool in identifying modulating agents of cell proliferation; antitumor agents
01/18/2011	CA2331460C Heterocyclic inhibitors of p38
01/13/2011	US20110009625 Novel compounds
01/13/2011	US20110009367 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
01/13/2011	US20110009319 Cripto antagonism of activin and tgf-b signaling
01/12/2011	EP2272833A1 2-(3-(4-(2-t-Butyl-6-trifluoromethylpyridin-4-yl)piperazin-1-yl)propylmercapto)pyrimidin-4-ol-fumarate
01/12/2011	EP2272516A2 4-Oxoquinoline compound and use thereof as HIV integrase inhibitor
01/12/2011	EP1682138B1 Heterocyclic inhibitors of mek
01/12/2011	CN101941968A Novel imidazopyridine compound ii with therapeutic effect
01/12/2011	CN101029022B Process for the preparation of 4-phenoxy quinoline derivatives
01/11/2011	US7868188 Phosphatidylinositol (PI) 3-kinase (PI3K); N-[5-(5-Benzylamino-6-chloropyridin-3-yl)-4-methyl-1,3-thiazol-2-yl]acetamide, for example; anticancer agents, cardiovascular disorders, autoimmune disorders, rheumatic diseases
01/11/2011	CA2518740C Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
01/11/2011	CA2451678C Azaindoles
01/11/2011	CA2387095C Compound with growth hormone releasing properties
01/06/2011	US20110003794 Naphthyridine Integrase Inhibitors
01/05/2011	EP2269651A2 Stabilisation of macrolides
01/04/2011	US7863284 such as N-{N-{4-[N-(2-methoxymethyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclo-penta[g]quinazolin-6-yl)-N-(prop-2-ynyl)amino]benzoyl}-L- gamma -glutamyl}-D-glutamic acid, used for aiding regression and palliation of ovarian cancer; antiproliferative agents
01/04/2011	CA2460822C Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing same
12/2010
12/29/2010	EP2266978A1 Novel physiologically active substances
12/29/2010	EP1001946B1 QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES
12/29/2010	CN1926132B Pyrazole compounds useful as protein kinase inhibitors
12/29/2010	CN101928262A Biologically active methylene blue derivatives
12/29/2010	CN101113137B Intermidiate for preparing 1,2-oxygen nitrogen heterocyclic-2-alkene acylbenzene and its preparation
12/28/2010	US7858824 Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing them
12/28/2010	US7858626 Pyrimidineamines as angiogenesis modulators
12/28/2010	US7858327 Using terminal kinase mutant as model for identifying modulator which treat, prevent or reduce incidence of premature aging; enzyme inhbitors; insulin receptor effectors

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 105